Posted Jun. 3, 2013 at 11:10 a.m.

Premium Lock GSK buys arthritis/multiple sclerosis candidate for $577M

Published: 2013-06-03 11:10:55
Updated: 2013-06-03 11:10:55


Glaxo acquires the rights to a German-based company's drug that is under clinical trial as a treatment for arthritis and multiple sclerosis. In other news, GSK reports the use of a breast cancer drug fails in a clinical trial as a treatment for gastic cancer....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy